Physician profile
Ramachander Nanduri
NPI 1093721896
$731.36
in general payments reported to CMS, 2019-2025
11 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.30 · 2021: $105 · 2022: $277 · 2023: $65.14 · 2024: $106 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $175.74 | 2022 | |
| Lilly USA, LLC | $136.51 | 2020-2023 | Jardiance, Emgality |
| Aurinia Pharma U.S., INC. | $105.60 | 2024 | Lupkynis |
| Novo Nordisk INC | $78.26 | 2025 | Wegovy |
| Dexcom, INC. | $48.43 | 2022-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $42.63 | 2021-2022 | |
| Genzyme Corporation | $38.82 | 2023 | |
| Cranial Technologies, INC | $29.33 | 2021 | |
| Seqirus USA INC | $27.28 | 2025 | Flucelvax |
| Hologic Sales and Service, LLC | $24.83 | 2025 | Aptima |
| Teleflex LLC | $23.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramachander Nanduri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.